As of Dec 09
| -0.06 / -5.00%|
The 3 analysts offering 12-month price forecasts for Apricus Biosciences Inc have a median target of 2.85, with a high estimate of 7.00 and a low estimate of 2.70. The median estimate represents a +150.00% increase from the last price of 1.14.
The current consensus among 3 polled investment analysts is to Buy stock in Apricus Biosciences Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.